FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124370594> ?p ?o ?g. }

• W2124370594 endingPage "4519" @default.
• W2124370594 startingPage "4511" @default.
• W2124370594 abstract "Abstract Purpose: FcγR polymorphisms have been reported to enhance the immune-mediated effects of cetuximab in metastatic colorectal cancer. There are no data on the relationship between these polymorphisms and cetuximab in the early-stage setting. We performed a pharmacogenomic analysis of EXPERT-C, a randomized phase II trial of neoadjuvant CAPOX followed by chemoradiotherapy, surgery, and adjuvant CAPOX ± cetuximab in high-risk, locally advanced rectal cancer. Experimental Design: FcγRIIa-H131R and FcγRIIIa-V158F polymorphisms were analyzed on DNA from peripheral blood samples. Kaplan–Meier method and Cox regression analysis were used to calculate survival estimates and compare treatment arms. Results: Genotyping was successfully performed in 105 of 164 (64%) patients (CAPOX = 54, CAPOX-C = 51). No deviation from the Hardy–Weinberg equilibrium or association of these polymorphisms with tumor RAS status was observed. FcγRIIa-131R (HR, 0.38; P = 0.058) and FcγRIIIa-158F alleles (HR, 0.21; P = 0.007) predicted improved progression-free survival (PFS) in patients treated with cetuximab. In the CAPOX-C arm, carriers of both 131R and 158F alleles had a statistically significant improvement in PFS (5 years: 78.4%; HR, 0.22; P = 0.002) and overall survival (OS; 5 years: 86.4%; HR, 0.24; P = 0.018) when compared with patients homozygous for 131H and/or 158V (5-year PFS: 35.7%; 5-year OS: 57.1%). An interaction between cetuximab benefit and 131R and 158F alleles was found for PFS (P = 0.017) and remained significant after adjusting for prognostic variables (P = 0.003). Conclusion: This is the first study investigating FcγRIIa and FcγRIIIa polymorphisms in patients with early-stage colorectal cancer treated with cetuximab. We showed an increased clinical benefit from cetuximab in the presence of 131R and 158F alleles. Clin Cancer Res; 20(17); 4511–9. ©2014 AACR." @default.
• W2124370594 created "2016-06-24" @default.
• W2124370594 creator A5001977752 @default.
• W2124370594 creator A5003463922 @default.
• W2124370594 creator A5025120810 @default.
• W2124370594 creator A5040619792 @default.
• W2124370594 creator A5045576082 @default.
• W2124370594 creator A5051974926 @default.
• W2124370594 creator A5052891683 @default.
• W2124370594 creator A5056345420 @default.
• W2124370594 creator A5057158252 @default.
• W2124370594 creator A5057249944 @default.
• W2124370594 creator A5059107350 @default.
• W2124370594 creator A5070390203 @default.
• W2124370594 creator A5079301374 @default.
• W2124370594 creator A5084395158 @default.
• W2124370594 creator A5086258366 @default.
• W2124370594 date "2014-09-01" @default.
• W2124370594 modified "2023-10-11" @default.
• W2124370594 title "<i>FcγRIIa</i>and<i>Fc<b><i>γ</i></b>RIIIa</i>Polymorphisms and Cetuximab Benefit in the Microscopic Disease" @default.
• W2124370594 cites W1484877475 @default.
• W2124370594 cites W1518617543 @default.
• W2124370594 cites W1817930542 @default.
• W2124370594 cites W1914229355 @default.
• W2124370594 cites W1937083157 @default.
• W2124370594 cites W1965205681 @default.
• W2124370594 cites W1965962344 @default.
• W2124370594 cites W1967218337 @default.
• W2124370594 cites W1991581538 @default.
• W2124370594 cites W1991842105 @default.
• W2124370594 cites W1997231093 @default.
• W2124370594 cites W1997695277 @default.
• W2124370594 cites W1999331938 @default.
• W2124370594 cites W2019195072 @default.
• W2124370594 cites W2036503037 @default.
• W2124370594 cites W2046281776 @default.
• W2124370594 cites W2051999609 @default.
• W2124370594 cites W2052341737 @default.
• W2124370594 cites W2060076416 @default.
• W2124370594 cites W2089103160 @default.
• W2124370594 cites W2093322080 @default.
• W2124370594 cites W2109502548 @default.
• W2124370594 cites W2119904228 @default.
• W2124370594 cites W2121910124 @default.
• W2124370594 cites W2122080125 @default.
• W2124370594 cites W2122618533 @default.
• W2124370594 cites W2128402413 @default.
• W2124370594 cites W2130930654 @default.
• W2124370594 cites W2131371081 @default.
• W2124370594 cites W2132352600 @default.
• W2124370594 cites W2134142320 @default.
• W2124370594 cites W2134918129 @default.
• W2124370594 cites W2141665958 @default.
• W2124370594 cites W2143847499 @default.
• W2124370594 cites W2143867423 @default.
• W2124370594 cites W2145127518 @default.
• W2124370594 cites W2150621467 @default.
• W2124370594 cites W2155311724 @default.
• W2124370594 cites W2589441907 @default.
• W2124370594 doi "https://doi.org/10.1158/1078-0432.ccr-14-0674" @default.
• W2124370594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24987061" @default.
• W2124370594 hasPublicationYear "2014" @default.
• W2124370594 type Work @default.
• W2124370594 sameAs 2124370594 @default.
• W2124370594 citedByCount "7" @default.
• W2124370594 countsByYear W21243705942015 @default.
• W2124370594 countsByYear W21243705942016 @default.
• W2124370594 countsByYear W21243705942017 @default.
• W2124370594 countsByYear W21243705942019 @default.
• W2124370594 crossrefType "journal-article" @default.
• W2124370594 hasAuthorship W2124370594A5001977752 @default.
• W2124370594 hasAuthorship W2124370594A5003463922 @default.
• W2124370594 hasAuthorship W2124370594A5025120810 @default.
• W2124370594 hasAuthorship W2124370594A5040619792 @default.
• W2124370594 hasAuthorship W2124370594A5045576082 @default.
• W2124370594 hasAuthorship W2124370594A5051974926 @default.
• W2124370594 hasAuthorship W2124370594A5052891683 @default.
• W2124370594 hasAuthorship W2124370594A5056345420 @default.
• W2124370594 hasAuthorship W2124370594A5057158252 @default.
• W2124370594 hasAuthorship W2124370594A5057249944 @default.
• W2124370594 hasAuthorship W2124370594A5059107350 @default.
• W2124370594 hasAuthorship W2124370594A5070390203 @default.
• W2124370594 hasAuthorship W2124370594A5079301374 @default.
• W2124370594 hasAuthorship W2124370594A5084395158 @default.
• W2124370594 hasAuthorship W2124370594A5086258366 @default.
• W2124370594 hasBestOaLocation W21243705941 @default.
• W2124370594 hasConcept C104317684 @default.
• W2124370594 hasConcept C121608353 @default.
• W2124370594 hasConcept C126322002 @default.
• W2124370594 hasConcept C135763542 @default.
• W2124370594 hasConcept C143998085 @default.
• W2124370594 hasConcept C2777863537 @default.
• W2124370594 hasConcept C2779998722 @default.
• W2124370594 hasConcept C31467283 @default.
• W2124370594 hasConcept C50382708 @default.
• W2124370594 hasConcept C526805850 @default.
• W2124370594 hasConcept C55493867 @default.
• W2124370594 hasConcept C71924100 @default.

• next